A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy
Clinical trial NCT05878561 · COMPLETED
Trial details
- NCT number
- NCT05878561
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-09
- Primary completion
- 2024-12-02
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.